U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

BioSpecifics Technologies Corp. (BSTC)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
46.16-0.22 (-0.47%)
At close: 4:00PM EDT

46.16 0.00 (0.00%)
After hours: 4:42PM EDT

People also watch
CBPOBWINBBMRCBMTCCASS
Full screen
Previous Close46.38
Open46.02
Bid0.00 x 0
Ask0.00 x 0
Day's Range45.63 - 47.11
52 Week Range41.00 - 58.79
Volume21,446
Avg. Volume25,135
Market Cap330.7M
Beta2.17
PE Ratio (TTM)28.32
EPS (TTM)1.63
Earnings DateMay 11, 2017 - May 12, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est72.00
Trade prices are not sourced from all markets
  • PR Newswire3 days ago

    BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

    LYNBROOK, N.Y., Sept. 20, 2017 /PRNewswire/ -- BioSpecifics Technologies Corp. (BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the upcoming 2017 Cantor Fitzgerald Global Healthcare Conference at 2:15 p.m. ET on Wednesday, September 27, 2017 in New York, NY. A live audio webcast of each presentation can also be accessed under the "Events and Presentation" tab in the Investors section of the Company's website at www.biospecifics.com or at http://wsw.com/webcast/cantor6/bstc. BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for thirteen clinical indications to date.

  • Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : September 18, 2017
    Capital Cube4 days ago

    Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : September 18, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Biospecifics Technologies Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Should You Buy BioSpecifics Technologies Corp (BSTC) At This PE Ratio?
    Simply Wall St.7 days ago

    Should You Buy BioSpecifics Technologies Corp (BSTC) At This PE Ratio?

    BioSpecifics Technologies Corp (NASDAQ:BSTC) trades with a trailing P/E of 28.7x, which is lower than the industry average of 37.2x. While BSTC might seem like an attractive stock to buy,Read More...